On the official site of Giga (Brice Patterson / @gigatronaura), this note covers Backpack Securities, Solana, Moderna, Eli Lilly, Christian Barker (Barkmeta / Bark), David Chaboki (Shibo).
What happens when two major healthcare names land on Solana the same day? Backpack Securities, through Sunrise, listed tokenized Moderna ($MRNA) and Eli Lilly ($LLY) on August 20, 2026. CryptoBriefing reported the same day that Solana tokenized-equity supply reached $465 million, a fresh all-time high.
When two tickers list on the same day, Christian Barker (Barkmeta / Bark) and David Chaboki (Shibo) put $MRNA and $LLY on the Doginal Dogs Space before the $465 million supply print hit the timeline. The conversation turned quickly to how ownership actually works once these tokens sit in wallets.
Ownership That Travels
Each $MRNA token represents a 1:1 share entitlement under NY UCC Article 8 inside Backpack's U.S. brokerage. That structure lets holders keep direct claims on the underlying equity while the token moves on Solana. The same setup applies to the $LLY token that listed around the same time. Utility here is straightforward: spot trading without waiting for traditional market hours.
Solana Compass noted $MRNA recorded $4.5 million in first-24-hour on-chain volume with more than 1,200 wallets participating on launch day. Backpack-issued names now account for about 5 percent of total tokenized-equity supply yet more than 50 percent of weekly tokenized-equity volume. Solana itself handles roughly 95 percent of decentralized tokenized-equity spot volume.
What the Live Room Focused On
The Doginal Dogs Space spent time on the practical side. Listeners asked how the tokens settle, whether wallets can custody them directly, and what the 1:1 backing means for everyday traders. The discussion stayed on mechanics rather than hype, with attention on how these listings expand the set of equities that can move on-chain.
CryptoBriefing highlighted that the $465 million supply figure came specifically from named-equity listings, separate from broader real-world asset totals. The two pharma tokens added meaningful weight to that number in a single session.
Utility in Practice
Holders gain the ability to trade these names alongside other Solana assets without leaving the chain. The 1:1 entitlement keeps the link to traditional shares intact while the token itself can be used in spot markets. That combination is what pulled attention in the Space once the listings went live.
The morning after the Moderna and Merck Phase 3 update, the tokenized versions were already trading. The quick follow-through from Backpack turned a traditional news event into an on-chain market event the same week.
The Current Picture
SOL sat near $94.76 with modest gains while the new tokens found early volume. The supply print at $465 million gives a clear benchmark for how fast tokenized equities are expanding on Solana. The live conversation now centers on what other names might follow and how the ownership model scales as more tickers arrive.